Immunovant Inc (NASDAQ:IMVT)
| 20.64 Delayed Data As of Jun 02 |  -0.04 / -0.19%Today’s Change | 3.15 Today|||52-Week Range 24.18 | +16.28% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Roivant Sciences Ltd |  Buy | 10/06/2022 | 416,667 | $6.00 | $2.5M | +110.39% |
Barnett Eva Renee Chief Financial Officer |  Sale | 10/11/2022 | 12,500 | $9.44 | $118.0K | +122.15% |
Pande Atul C Director | Buy | 9/30/2022 | 15,000 | $5.60 | $84.0K | +270.25% |
Barnett Eva Renee Chief Financial Officer | Sale | 4/18/2023 | 3,423 | $15.27 | $52.3K | +30.93% |
Salzmann Peter /stahl/ Chief Executive Officer | Sale | 4/18/2023 | 3,395 | $15.27 | $51.8K | +30.93% |
Levine Mark S /minerva/ Chief Legal Officer | Sale | 4/25/2023 | 2,633 | $16.29 | $42.9K | +27.77% |
Salzmann Peter /stahl/ Chief Executive Officer | Sale | 10/13/2022 | 2,793 | $9.18 | $25.6K | +120.96% |
Butchko Julia G Chief Development Officer | Sale | 4/18/2023 | 1,544 | $15.27 | $23.6K | +30.93% |
Salzmann Peter /stahl/ Chief Executive Officer | Sale | 8/30/2022 | 1,644 | $5.83 | $9.6K | +298.84% |
Butchko Julia G | Sale | 10/13/2022 | 928 | $9.18 | $8.5K | +120.96% |
Page of 4